There were quite a few surprises in the market. ITC went over the Rs 807 mark, which could well mean that it has launched into a new and higher orbit. BHEL continued to surge ahead. Having crossed the Rs 279 border, it appears to be emboldened to drive up further. The scrip will now meet with a technical resistance at Rs 307. HPCL's technical formation is not healthy. Therefore, I would treat the rise with caution. However, if it breaks the Rs 245 barrier, you could get bullish in this counter. Hindalco has a resistance at Rs 555.

Cement scrips have begun an upward spiral. Larsen & Toubro, Gujarat Ambuja and Grasim are only the scrips in the Sensex folder. But many other smaller scrips outside the A group have started moving up. On the pharma front, even though scrips in this sector in the Sensex list have come up with resistance, many other pharma scrips have started rising. Investors would do well to check out the opportunities available here. Many are available at attractive evaluations.

The Sensex cleared an important resistance level at 3,268 points. It's next target would be 3,450 points. With Reliance Industries and SBI growing stronger, it would not be difficult for the index to reach this level. It is time that you took hold of opportunities in the non-A group stocks as well.